Sponsor

Camp4 Therapeutics Corp.

United States 1 Kendall Square, MA, 02139-1562, United States

About the sponsor

Camp4 Therapeutics Corp. focuses its clinical research on urea cycle disorders, with particular attention to ornithine transcarbamylase deficiency and related metabolic disorders affecting ammonia detoxification.

Ornithine transcarbamylase genotype-linked disease
Inherited metabolic disease
Hepatic urea cycle function

The sponsor’s research activity in this area is centered on rare genetic metabolic disease and the clinical needs of individuals with impaired urea cycle activity.

About Specializations

Camp4 Therapeutics Corp. runs clinical trials in conditions such as Urea cycle disorder, among others.

Urea cycle disorder

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Urea cycle disorder

Not yet recruiting

Study of CMP-CPS-001 injection in healthy volunteers and patients with abnormal ornithine transcarbamylase (OTC) genotype for treating urea cycle disorders

Investigational